Kathleen Lang

927 total citations
33 papers, 764 citations indexed

About

Kathleen Lang is a scholar working on Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kathleen Lang has authored 33 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kathleen Lang's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Economic and Financial Impacts of Cancer (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kathleen Lang is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Economic and Financial Impacts of Cancer (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kathleen Lang collaborates with scholars based in United States, Canada and Estonia. Kathleen Lang's co-authors include Joseph Menzin, Craig C. Earle, David W. Lee, Jonathan R. Korn, Rajiv Mallick, Arnold L. Potosky, Joan L. Warren, Ann B. Nattinger, Lisa M. Lines and Mark S. Berger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medical Care.

In The Last Decade

Kathleen Lang

32 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Lang United States 16 246 162 155 115 93 33 764
Chintan Pandya United States 15 333 1.4× 180 1.1× 126 0.8× 89 0.8× 196 2.1× 43 967
Anthony Matthews Sweden 16 235 1.0× 102 0.6× 170 1.1× 127 1.1× 85 0.9× 44 1.1k
Clark DuMontier United States 16 241 1.0× 156 1.0× 134 0.9× 60 0.5× 141 1.5× 62 890
Talia Foster United States 13 132 0.5× 90 0.6× 221 1.4× 64 0.6× 84 0.9× 15 742
Maria Theresa Redaniel United Kingdom 19 387 1.6× 74 0.5× 111 0.7× 94 0.8× 194 2.1× 66 941
Jacqueline Brown United Kingdom 20 279 1.1× 162 1.0× 273 1.8× 246 2.1× 113 1.2× 50 1.4k
Marianne Laouri United States 17 176 0.7× 250 1.5× 64 0.4× 92 0.8× 104 1.1× 30 1.3k
Tochi M. Okwuosa United States 17 210 0.9× 54 0.3× 167 1.1× 60 0.5× 70 0.8× 44 1.1k
Ravinder Dhawan United States 17 257 1.0× 145 0.9× 146 0.9× 125 1.1× 61 0.7× 42 1.3k
Allison Petrilla United States 13 75 0.3× 126 0.8× 80 0.5× 80 0.7× 74 0.8× 45 739

Countries citing papers authored by Kathleen Lang

Since Specialization
Citations

This map shows the geographic impact of Kathleen Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Lang more than expected).

Fields of papers citing papers by Kathleen Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Lang. The network helps show where Kathleen Lang may publish in the future.

Co-authorship network of co-authors of Kathleen Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Lang. A scholar is included among the top collaborators of Kathleen Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Lang. Kathleen Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lang, Kathleen, et al.. (2016). Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis. Allergy and Asthma Proceedings. 37(5). 103–111. 7 indexed citations
4.
Lang, Kathleen, et al.. (2016). Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data. Clinical Lymphoma Myeloma & Leukemia. 16(5). 275–285.e1. 13 indexed citations
5.
Lang, Kathleen, Aarti A. Patel, Winnie W. Nelson, et al.. (2014). Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis. BMC Health Services Research. 14(1). 329–329. 25 indexed citations
6.
Lang, Kathleen, et al.. (2014). Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy. Journal of Comparative Effectiveness Research. 3(5). 481–490. 3 indexed citations
7.
Lang, Kathleen, Jonathan R. Korn, Erik Muser, et al.. (2011). Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics. Journal of Medical Economics. 14(2). 217–226. 31 indexed citations
8.
Lang, Kathleen, et al.. (2010). Development of an Interactive Model of the Burden of Future Coronary Heart Disease From an Employer Perspective. Journal of Occupational and Environmental Medicine. 52(9). 851–857. 3 indexed citations
9.
Lang, Kathleen, et al.. (2009). Trends in healthcare utilization among older Americans with colorectal cancer: A retrospective database analysis. BMC Health Services Research. 9(1). 227–227. 15 indexed citations
10.
Lang, Kathleen, Martin Marciniak, Douglas E. Faries, et al.. (2009). Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States. Value in Health. 12(4). 481–488. 21 indexed citations
11.
Lang, Kathleen, Martin Marciniak, D Faries, et al.. (2008). Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States. Lung Cancer. 63(2). 264–270. 50 indexed citations
12.
Lang, Kathleen, Natalya Danchenko, Kathleen Gondek, Brian Schwartz, & David Thompson. (2007). The burden of illness associated with renal cell carcinoma in the United States. Urologic Oncology Seminars and Original Investigations. 25(5). 368–375. 29 indexed citations
13.
Lang, Kathleen, Natalya Danchenko, Kathleen Gondek, Brian Schwartz, & D. Thompson. (2006). Burden of illness analysis of renal cell carcinoma. Journal of Clinical Oncology. 24(18_suppl). 14548–14548. 2 indexed citations
14.
15.
Lang, Kathleen, et al.. (2005). Trends in the Treatment of Acute Myeloid Leukaemia in the Elderly. Drugs & Aging. 22(11). 943–955. 77 indexed citations
16.
Lang, Kathleen, Margit Mägi, & Tiiu Aareleid. (2003). Study of completeness of registration at the Estonian cancer registry. European Journal of Cancer Prevention. 12(2). 153–156. 19 indexed citations
17.
Lang, Kathleen, Joseph Menzin, Craig C. Earle, & Rajiv Mallick. (2002). Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia. American Journal of Health-System Pharmacy. 59(10). 941–948. 3 indexed citations
18.
Earle, Craig C., Ann B. Nattinger, Arnold L. Potosky, et al.. (2002). Identifying Cancer Relapse Using SEER-Medicare Data. Medical Care. 40(Supplement). IV–75. 112 indexed citations
19.
Menzin, Joseph, Kathleen Lang, Pierre Lévy, & Émile Lévy. (2001). A General Model of the Effects of Sleep Medications on the Risk and Cost of Motor Vehicle Accidents and its Application to France. PharmacoEconomics. 19(1). 69–78. 21 indexed citations
20.
Martin, Bradley C., et al.. (2000). The Net Cost of Alzheimer Disease and Related Dementia: A Population-Based Study of Georgia Medicaid Recipients. Alzheimer Disease & Associated Disorders. 14(3). 151–159. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chintan Pandya Breakdown of academic impact, for papers by Anthony Matthews Breakdown of academic impact, for papers by Clark DuMontier Breakdown of academic impact, for papers by Talia Foster Breakdown of academic impact, for papers by Maria Theresa Redaniel Breakdown of academic impact, for papers by Jacqueline Brown Breakdown of academic impact, for papers by Marianne Laouri Breakdown of academic impact, for papers by Tochi M. Okwuosa Breakdown of academic impact, for papers by Ravinder Dhawan Breakdown of academic impact, for papers by Allison Petrilla
Rankless by CCL
2026